You are here: Industry Insights > Cardinal Health

News List

2022 — a turning point for US biosimilars? CPhIonline
February 10, 2022
Cardinal Health says the majority of healthcare providers are keen to use biosimilars despite current market challenges.
Mental health distress impacting cancer patients, says new Cardinal Health survey of oncologists prnewswire
December 10, 2021
More than 80% of oncologists frequently see mental health distress in their patients with cancer, and more than 90% say it has a significant impact on their health outcomes.
Clarity and Cardinal Health enter into Agreement for Targeted Copper Theranostics prnasia
December 03, 2021
Clarity Pharmaceuticals (ASX: CU6) ("Clarity"), a clinical-stage radiopharmaceutical company developing next-generation products to address the growing needs in oncology, and Cardinal Health (NYSE: CAH)...
Cardinal Health partners with Abbott and Quidel to offer rapid OTC COVID-19 tests prnewswire
August 11, 2021
Cardinal Health (NYSE: CAH) today announced its efforts to commercialize and broaden access to over-the-counter rapid COVID-19 tests through partnerships with Abbott and Quidel Corporation ("Quidel").
Cardinal Health completes sale of Cordis business to Hellman & Friedman prnasia
August 03, 2021
Cardinal Health and Hellman & Friedman announced the completion of the previously announced sale of Cardinal Health's Cordis business to H&F.
New York, drug distributors reach $1.18 billion opioid settlement as national deal looms expresspharma
July 22, 2021
The three largest US drug distributors agreed mid-trial to pay up to $1.18 billion to settle claims by New York state and two of its biggest counties over their role in the nation-wide opioid epidemic, the state’s attorney general said 20th.
FDA Statement on Cardinal Health Surgical Gowns, Packs Quality americanpharmaceuticalreview
January 19, 2020
On Jan. 11 and again on Jan. 15, 2020, medical device manufacturer Cardinal Health alerted its customers to potential quality issues affecting some of its Level 3 surgical gowns and PreSource procedural packs that contain these gowns.
Cardinal Health sells off China business to Shanghai Pharma biospectrumasia
November 17, 2017
The $557 million is calculated after deduction of debt and other adjustments from the base payment that values the unit at $1.2 billion.
Cardinal Health Completes Acquisition of Medtronic's Patient Recovery Business americanpharmaceuticalreview
August 02, 2017
Cardinal Health has completed the acquisition of Medtronic's Patient Care, Deep Vein Thrombosis and Nutritional Insufficiency business for $6.1 billion.
Cardinal Health to Acquire Patient Product Portfolio from Medtronic for $6.1 Billion americanpharmaceuticalreview
April 20, 2017
Cardinal Health has entered into a definitive agreement to acquire Medtronic's Patient Care, Deep Vein Thrombosis and Nutritional Insufficiency businesses for $6.1 billion in cash. The purchase price does not include cash tax benefits of at least $100 mil